Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for Neurogene (NGNE) over the last 5 years, with Q3 2025 value amounting to $21.9 million.

  • Neurogene's Total Non-Current Liabilities fell 1609.75% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year decrease of 1609.75%. This contributed to the annual value of $24.6 million for FY2024, which is 3068.4% down from last year.
  • Neurogene's Total Non-Current Liabilities amounted to $21.9 million in Q3 2025, which was down 1609.75% from $23.3 million recorded in Q2 2025.
  • Neurogene's Total Non-Current Liabilities' 5-year high stood at $35.5 million during Q4 2023, with a 5-year trough of $21.9 million in Q3 2025.
  • Its 3-year average for Total Non-Current Liabilities is $25.3 million, with a median of $23.9 million in 2024.
  • As far as peak fluctuations go, Neurogene's Total Non-Current Liabilities plummeted by 3068.4% in 2024, and later tumbled by 319.19% in 2025.
  • Neurogene's Total Non-Current Liabilities (Quarter) stood at $35.5 million in 2023, then tumbled by 30.68% to $24.6 million in 2024, then decreased by 11.25% to $21.9 million in 2025.
  • Its Total Non-Current Liabilities stands at $21.9 million for Q3 2025, versus $23.3 million for Q2 2025 and $22.8 million for Q1 2025.